Indication

Cardiac transplant rejection

Cardiac transplant rejection is an immunologic complication occurring in heart transplant recipients when the host immune system recognizes human leukocyte antigens on the donor allograft as foreign. Read more about Cardiac transplant rejection

1 drugs 1 manufacturers

Drugs that treat it

Common Cardiac transplant rejection therapies.

Showing 1–1 of 1 drugs

Sort

ORTHOCLONE OKT3 (muromonab-CD3)

KIDNEY TRANSPLANT REJECTION·+2

CENTOCOR ORTHO

Filter & compare in the drug finder →Opens the drug finder with Cardiac transplant rejection preselected.

News & literature

Coming soon

Related codes

Coming soon

About Cardiac transplant rejection.

Cardiac transplant rejection is an immunologic complication occurring in heart transplant recipients when the host immune system recognizes human leukocyte antigens on the donor allograft as foreign.

It encompasses hyperacute rejection caused by preformed anti-donor antibodies, acute cellular rejection driven by T-lymphocyte-mediated cytotoxicity, antibody-mediated rejection involving microvascular endothelial damage and complement activation, and chronic rejection manifesting primarily as cardiac allograft vasculopathy.

Clinically, these processes lead to myocardial inflammation, interstitial edema, myocyte necrosis, and progressive graft dysfunction, which can precipitate arrhythmias, heart failure, and potential allograft failure.

nih.gov
Cardiac transplant rejection is an immunologic complication occurring in heart transplant recipients when the host immune system recognizes human leukocyte antigens on the donor allograft as foreign It encompasses hyperacute rejection caused by preformed anti-donor antibodies, acute cellular rejection driven by T-lymphocyte-mediated cytotoxicity, antibody-mediated rejection involving microvascular endothelial damage and complement activation, and chronic rejection manifesting primarily as cardia...
nih.gov
Cardiac transplant rejection is an immunologic complication occurring in heart transplant recipients when the host immune system recognizes human leukocyte antigens on the donor allograft as foreign Clinically, these processes lead to myocardial inflammation, interstitial edema, myocyte necrosis, and progressive graft dysfunction, which can precipitate arrhythmias, heart failure, and potential allograft failure
medlineplus.gov
Cardiac transplant rejection is an immunologic complication occurring in heart transplant recipients when the host immune system recognizes human leukocyte antigens on the donor allograft as foreign
cedars-sinai.org
It encompasses hyperacute rejection caused by preformed anti-donor antibodies, acute cellular rejection driven by T-lymphocyte-mediated cytotoxicity, antibody-mediated rejection involving microvascular endothelial damage and complement activation, and chronic rejection manifesting primarily as cardiac allograft vasculopathy
nih.gov
It encompasses hyperacute rejection caused by preformed anti-donor antibodies, acute cellular rejection driven by T-lymphocyte-mediated cytotoxicity, antibody-mediated rejection involving microvascular endothelial damage and complement activation, and chronic rejection manifesting primarily as cardiac allograft vasculopathy
nih.gov
Clinically, these processes lead to myocardial inflammation, interstitial edema, myocyte necrosis, and progressive graft dysfunction, which can precipitate arrhythmias, heart failure, and potential allograft failure

Personalize your experience

Follow Cardiac transplant rejection and get updates as they land.

Create a free account

Already a member? Sign in

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it